Axa S.A. Myriad Genetics Inc Transaction History

Axa S.A.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$22.08 - $47.08 $1.92 Million - $4.09 Million	-86,787 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$22.67 - $35.0 $362,720 - $560,000	-16,000 Reduced 15.57%	86,787 $2.41 Million
Q1 2019 May 14, 2019	BUY	$26.93 - $34.7 $460,503 - $593,370	17,100 Added 19.96%	102,787 $3.41 Million
Q4 2018 Feb 13, 2019	BUY	$27.23 - $45.56 $1.17 Million - $1.96 Million	43,087 Added 101.14%	85,687 $2.49 Million
Q3 2018 Nov 08, 2018	SELL	$37.57 - $50.34 $1.04 Million - $1.4 Million	-27,800 Reduced 39.49%	42,600 $1.96 Million
Q2 2018 Aug 13, 2018	SELL	$27.75 - $40.17 $163,725 - $237,003	-5,900 Reduced 7.73%	70,400 $2.63 Million
Q1 2018 May 14, 2018	BUY	$28.83 - $41.01 $256,586 - $364,989	8,900 Added 13.2%	76,300 $2.26 Million
Q4 2017 Feb 13, 2018	BUY	$28.45 - $37.14 $1.92 Million - $2.5 Million	67,400	67,400 $2.32 Million

227

92M

297K

20.7K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.17B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

Stay updated on Axa S.A. with notifications on news.